Precipio Inc (PRPO) is a Healthcare · Diagnostics & Research company listed on NASDAQ. Price $26.06 (-1.44%), Market cap $0.05B, 52-week low–high $7.88 ~ $32.37.
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.
Financial statements, price targets, institutional (13F) holdings and related news for Precipio Inc are updated in real time on BlackAll Trade.
Precipio Inc trades at $26.06 (-1.44%). Real-time quotes and charts are available on BlackAll Trade.
Precipio Inc has a market cap of about $0.05B.
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company